ADAMS RESPIRATORY THERAPEUTICS, INC. – Trademark Portfolio
Entity Type: 03
ADAMS RESPIRATORY THERAPEUTICS, INC. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MUCINEX and MR. MUCUS. The owner is based in CHESTER, NJ.
425 MAIN STREET
CHESTER, NJ 07930
Showing of trademarks Trademarks
Trademark Classifications
ADAMS RESPIRATORY THERAPEUTICS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does ADAMS RESPIRATORY THERAPEUTICS, INC. have?
ADAMS RESPIRATORY THERAPEUTICS, INC. has 14 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 abandoned, 8 cancelled.
What trademark classes does ADAMS RESPIRATORY THERAPEUTICS, INC. file in?
ADAMS RESPIRATORY THERAPEUTICS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ADAMS RESPIRATORY THERAPEUTICS, INC.'s most well-known trademarks?
ADAMS RESPIRATORY THERAPEUTICS, INC.'s registered trademark portfolio includes well-known marks such as MUCINEX and MR. MUCUS. These are among 2 currently registered trademarks in the portfolio.
What is ADAMS RESPIRATORY THERAPEUTICS, INC.'s trademark registration success rate?
ADAMS RESPIRATORY THERAPEUTICS, INC. has a 14% trademark registration rate, with 2 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.